Latest updates for Biotech Beast

Fresh curated links around Biotech Beast are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
  • How Colossal is incubating an empire of startups
  • With $263M, LifeMine unearths a new drug for organ transplants

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

techcrunch.com /1 month ago

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Read source
fastcompany.com /2 weeks ago

How Colossal is incubating an empire of startups

Colossal Biosciences claims to have brought back the dire wolf, and is now hard at work on its quest to resurrect several other species, including the woolly mammoth and the moa, a...

Read source
biopharmadive.com /1 month ago

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Read source
pharmexec.com /1 week ago

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

Read source
qchron.com /2 weeks ago

Sunshine Guojian Releases 2026 Interim Report:

Innovation-driven, Steady Advancement

Read source
genengnews.com /1 month ago

NSF-Funded Test Bed Lets Researchers Program Automated Biomanufacturing Workflows

The CRAB Lab builds on a long-standing partnership between UMD and NIST through IBBR, which will serve as the physical home for instrumentation, facilities, and scientific expertis...

Read source
genengnews.com /2 weeks ago

Affordable Bioreactor Helps Prep Students for Biomanufacturing Careers

A bioreactor designed to test biosensors that measure multiple parameters in real time is being developed as a simple, budget-friendly bioreactor for high schools and colleges to h...

Read source
ft.com /1 month ago

Biotech deals surge to record as fear of missing out grips Big Pharma

Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines

Read source
fiercebiotech.com /1 month ago

Building a workforce engine for biomanufacturing

Ohio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.

Read source
e27.co /1 month ago

The 27 SEA biotech firms betting on cells, fermentation, and code

Southeast Asia’s startup story is usually told through ride-hailing, fintech, and e-commerce. But a quieter, stranger, and potentially more consequential sector is taking shape in...

Read source
fiercebiotech.com /1 week ago

From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple

The overwhelming demand for GLP-1 weight loss drugs has reshaped the drug market, empowering consumers to take charge of their own health and removing barriers between their wallet...

Read source
labiotech.eu /1 week ago

Genomes to bioreactors: Saudi Arabia’s gene editing oncology push

Saudi Arabia is pairing gene editing breakthroughs with new biomanufacturing capacity, from CRISPR oncology therapies to CDMOs like Lifera, as it builds a full biotech pipeline. Th...

Read source
genengnews.com /1 month ago

AI Protein Engineering Model Designed for Biomanufacturing

Generating biomanufacturing-relevant data on protein production in a large-scale, AI-enabled database is still rare. When commercialized, it may substantially improve development t...

Read source
biopharmadive.com /1 week ago

This week in charts: Biotech’s rebound is undeniable

Not only is the XBI continuing to hover around a historic high, but drug companies can’t seem to get enough of both large IPOs and big-ticket M&A.

Read source
genengnews.com /4 weeks ago

The State of Biotech 2026

The world of biotech is showing strong signs of growth and clinical impact while also experiencing new challenges. The explosion of AI is reshaping areas from drug discovery and pr...

Read source
genengnews.com /4 weeks ago

Biopharma’s Drawdown Is a Chance to Build Biotech Back Better

American biotechnology hubs like Boston, Seattle, and San Diego are starting to wake up again. But will they be able to learn from the lessons of the recent past? The post Biopharm...

Read source
fiercebiotech.com /1 month ago

5 emerging biotech hubs

Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in th...

Read source
biopharmadive.com /1 month ago

From confidence to capital: Positioning biotech for the next growth cycle

How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.

Read source
labiotech.eu /2 weeks ago

Could your microbial process be stronger? Uncovering opportunities before scale-up and commercialization

Discover how small adjustments make your microbial process more robust and reproducible during scale-up and technology transfer. The post Could your microbial process be stronger?...

Read source
genengnews.com /1 week ago

Bicistornic Vectors + piggyBac = Improved Antibody Cell Line Production

To produce stable cell lines for monoclonal antibody production, manufacturers typically use the piggyBac transposon system. For larger, multi-specific antibodies that have payload...

Read source
newswire.com /3 weeks ago

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Target...

Optimized process delivered a 10-fold improvement in productivity, significantly improving the estimated economics of future commercial-scale manufacturing.Estimated manufacturing...

Read source
techcrunch.com /1 month ago

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.

Read source
seekingalpha.com /1 week ago

Cogent Biosciences: 3 NDAs Create A Time-To-Market Moat

Read source
seekingalpha.com /3 weeks ago

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Biotech Beast

e27.co

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source